- Details
- Hits: 716
This just one individual and health care system crippling outcome of cannabis use is unstainable for any healthcare system, free or paid for. The cannabis lobby and industry continue to deflect, as does the cannabis user, at this growing endemic and the outrageous expense it is incurring on non-drug using tax-payers.
See also:
- Details
- Hits: 862
A new study from Aarhus University Hospital in Denmark has discovered the chronic use of marijuana is linked to as much as a four-fold increase in risk for major depressive disorder, bipolar disorder and associated psychosis.
The news is significant given the rapid increase in US states permitting recreational use of the drug…Although many Americans view pot use as relatively benign, new research is indicating a far greater risk than originally thought.
A study published in the journal Psychological Medicine and sponsored by the National Institutes of Health found a striking link between marijuana use and schizophrenia in young men, with indications use of the drug may be responsible for as much as 30% of cases. There was a similar link for females, but at a far lower rate, roughly 4%.
However, when the age cohort is lowered, indications are that there is a six-times greater risk for schizophrenia among teens who use the drug as little as once a week. The study, published in the Journal of Clinical Psychology, examined marijuana use across the globe.
New research from University of Washington and Kaiser Permanente Washington Health Research Institute estimates 21 percent of marijuana users had become addicted. The National Institute for Drug Abuse, (NIDA) has estimated that at least four million Americans have developed “marijuana use disorder” since cannabis became more widely available.
New Study: Marijuana Use Presents Four Times Higher Risk of Serious Mental Health Consequences
- Details
- Hits: 774
T.H.C – The Human Consequences: Why legalisation is a public and personal health nightmare.
- Details
- Hits: 810
A look at the association between cannabis use and schizophrenia, as well as the need for comprehensive public health policies and education.
September 25, 2023 Victor Ajluni, MD
The increasing acceptance and legalization of cannabis use worldwide has underscored the need to understand its potential health implications. One area of significant concern is the association between cannabis use and schizophrenia, a severe mental disorder characterized by thought and emotional disturbances. This association is particularly important, given the global burden of schizophrenia, which affects more than 20 million individuals worldwide, according to the World Health Organization.1
A Mendelian randomization study by Vaucher, et al, provided observational evidence of an increased risk of schizophrenia associated with cannabis use.2 Rentero, et al, highlighted the importance of differentiating between cannabis-induced psychosis and schizophrenia for therapeutic purposes.3 Ortiz-Medina, et al, emphasized the need for more research to fully understand the relationship between cannabis use and psychosis.4
Urits, et al, found that about 1 in 4 patients with schizophrenia are also diagnosed with cannabis use disorder (CUD), indicating a strong association between cannabis use and psychological disorders.5 Marconi, et al, reported a dose-response relationship between the level of cannabis use and the risk of psychosis, suggesting that higher levels of cannabis use could lead to long-lasting psychotic disorders.6
García Álvarez, et al, explored the impact of cannabis use on cognitive impairment in schizophrenia and first-episode psychosis, providing further evidence of the potential risks associated with cannabis use.7 Cohen, et al, discussed both the positive and negative effects of cannabis and cannabinoids on health, including their association with cognitive alterations, psychosis, and schizophrenia.8
In a comprehensive review published in The Lancet, Jauhar, et al, discussed the etiological and therapeutic challenges of schizophrenia, including the role of cannabis as a potential causative factor. They highlighted that cannabis and childhood adversity are areas of debate as causative factors for schizophrenia, emphasizing the need for further research in these areas.9
In their review, Lowe, et al, emphasized the need to gauge the potential impact of cannabis legalization on vulnerable populations, such as those with mental illnesses including schizophrenia. They discussed the potential for cannabis to induce long-term psychiatric effects, including the exacerbation of symptoms in individuals with preexisting psychiatric conditions like schizophrenia.10
Lastly, Hamilton discussed the complex interaction between cannabis, psychosis, and schizophrenia. He highlighted the need for a credible contribution to public health in light of increasing cannabis legalization. His study provided evidence of a dose-response relationship between cannabis use and the risk of psychosis, emphasizing that the risk increases with the frequency of use and the potency of cannabis.11
In conclusion, although the acceptance and legalization of cannabis continue to grow, it is crucial to consider the potential risks associated with cannabis use. The association between cannabis use and schizophrenia underscores the need for comprehensive public health policies and education to mitigate these risks. Further research is needed to fully elucidate the complex interaction between cannabis use, psychosis, and schizophrenia
- Details
- Hits: 709
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada
Aim: To measure the association between cannabis use disorder (CUD) and adverse cardiovascular disease (CVD) outcomes.
Participants: We identified participants with CUD diagnosis codes and matched them to participants without CUD codes by gender, year of birth and time of presentation to the health system. We included 29 764 pairs (n = 59 528 individuals in total).
Conclusions: Canadian adults with cannabis use disorder appear to have an approximately 60% higher risk of experiencing incident adverse cardiovascular disease events than those without cannabis use disorder.
(Research: https://onlinelibrary.wiley.com/doi/10.1111/add.16337 )
Also see
- Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
- How Cannabis Defeats Itself When Used Too Frequently
- Victorian government to trial the impacts of medicinal cannabis use on driving – Hmm, but who is overseeing the trial, and outcomes will emerge?
- Cannabis Use & Perinatal Health Research (JAMA)